CJC-1295 no DAC + Ipamorelin 20MG
Size
10MG CJC-1295 no DAC + 10MG Ipamorelin / vial — 20MG combined
Form
Research material
Purity
≥ 99%
Storage
-20°C, desiccated
Quantity pricing
Limit 10 per order. Ships within 24 hours.
For research use only. All products are intended strictly for laboratory research and in-vitro use only. Not for human or veterinary consumption, diagnostic, or therapeutic use. Products are not drugs, foods, cosmetics, or dietary supplements and may not be misbranded, misused, or mislabeled.
Description
This blend pairs two mechanistically complementary GH-axis research compounds: CJC-1295 (no DAC), a GHRH analog acting at the GHRH receptor, and Ipamorelin, a selective ghrelin-receptor agonist. The rationale for studying them together comes from secretagogue physiology — GHRH and ghrelin-mimetic signaling converge on somatotroph cells through distinct receptors, and preclinical literature has explored whether combined stimulation produces synergistic growth hormone release compared with either pathway alone. Rather than sourcing and combining the materials separately, laboratories use this pre-formulated blend to ensure consistent ratios across experimental cohorts, which matters for reproducibility in comparative secretagogue studies. Research applications include GH pulse-pattern analysis, receptor crosstalk investigation, and head-to-head comparisons against single-agent arms. Each component retains the analytical profile of its standalone presentation, verified by HPLC and mass spectrometry. This pairing is among the most frequently referenced combination protocols in the secretagogue literature, making the blend a practical standard for laboratories entering GH-axis research. For laboratory research use only. Not for human or veterinary use.
Research Peptide (CJC-1295 No DAC)
Key Features
- CJC-1295 no DAC and Ipamorelin combination studied in growth-hormone signaling research.
- 10MG/10MG formulation provides two research peptides for controlled laboratory comparison.
- Suitable for studies of GHRH-related and receptor-mediated peptide signaling.
- Intended exclusively for laboratory and research use.
Frequently asked questions
How much of each component is in the 20MG CJC/Ipamorelin vial?
The owner-confirmed formulation is 10MG CJC-1295 no DAC plus 10MG Ipamorelin, making 20MG combined material per vial. This is different from a 10MG blend containing 5MG of each component.
How should the CJC-1295 no DAC Ipamorelin 10MG/10MG quantity and batch identity be checked?
Read the quantity on the CJC-1295 no DAC Ipamorelin 10MG/10MG vial label separately from the analytical identity and purity results. Match the product and lot identifier to the available report; a research article is not a certificate for this supplied batch.
What is the purity of CJC-1295 no DAC + Ipamorelin 20MG?
Review the matching report for CJC-1295 no DAC + Ipamorelin 20MG in the COA library. Read the reported method, identity information and purity result together, and match the lot identifier to the supplied material.
Is a Certificate of Analysis included with CJC-1295 no DAC + Ipamorelin 20MG?
Browse the published COA library for CJC-1295 no DAC + Ipamorelin 20MG. Confirm that an available report matches the supplied product and lot; contact NUPEPS for current batch documentation before purchase.
How fast is shipping for CJC-1295 no DAC + Ipamorelin 20MG?
Orders placed before 3PM EST ship the same business day from our USA facility. Estimated delivery is 2 business days. Flat $15 shipping per order.
Is CJC-1295 no DAC + Ipamorelin 20MG for human use?
No. CJC-1295 no DAC + Ipamorelin 20MG is strictly for laboratory research use only. Not for human or veterinary consumption, diagnostic, or therapeutic use.
Research guides
Explore background and published research related to this compound.